| Announce Date | 11/05/2025 |
| EPS Normalized Actual | $2.27 (Beat by $0.04) |
| EPS GAAP Actual | $2.27 (Beat by $0.04) |
| Revenue Actual | $22.155B |
| Revenue Surprise | Beat by $22155M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $2.29036 |
| EPS GAAP Estimate | $2.29036 |
| Revenue Estimate | $15.381094295B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 9.28522 | 9.94 | 8.67381 | 9.9133 | 2 |
| Dec 2026 | 10.3554 | 8.91 | 9.89628 | 11.40704 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.84 | -1.32909 | 22.155B | 41.74% | 6972.62M |
| FQ2 2025 (Jun 2025) | 2.6 | 0.29558 | 12.769B | -3.7% | -2413.38M |
| FQ1 2025 (Mar 2025) | 1.5 | 1.5 | 11.643B | -15.24% | 11643M |
| FQ4 2024 (Dec 2024) | 4.36 | 4.36 | 13.542B | -10.28% | 13542M |
| FQ3 2024 (Sep 2024) | 0 | 0 | 12.908B | -10.22% | 12908M |
| FQ2 2024 (Jun 2024) | 0.49 | 0.49 | 13.241B | -13.65% | 13241M |
| FQ1 2024 (Mar 2024) | 1.7 | 1.7 | 13.417B | -14.24% | 13417M |
| FQ4 2023 (Dec 2023) | 4.19 | 4.19 | 14.934B | -11.56% | 14934M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
2.29036
Consensus Revenue Estimates
15.381094295B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.31069 | -- | 2.31069 | 2.31069 | 2 |
| FQ3 2027 (Sep 2027) | 0 | -- | 0 | 0 | 1 |
| FQ2 2027 (Jun 2027) | 0 | -- | 0 | 0 | 1 |
| FQ1 2027 (Mar 2027) | 0 | -- | 0 | 0 | 1 |
| FQ4 2026 (Oct 2026) | 2.46437 | -- | 2.26718 | 2.79389 | 3 |
| FQ3 2026 (Jul 2026) | 2.45391 | 65.77 | 2.25756 | 2.78203 | 3 |
| FQ2 2026 (Jun 2026) | 2.45391 | -5.95 | 2.23452 | 2.79259 | 1 |
| FQ1 2026 (Mar 2026) | 2.44354 | 38.61 | 2.22507 | 2.78079 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 18.78B | -- | 18.78B | 18.78B | 1 |
| FQ3 2027 (Sep 2027) | 21.92B | -- | 21.57B | 22.62B | 2 |
| FQ2 2027 (Jun 2027) | 22.28B | -- | 21.93B | 23B | 2 |
| FQ1 2027 (Mar 2027) | 21.34B | -- | 21B | 22.03B | 2 |
| FQ4 2026 (Oct 2026) | 16.66B | -- | 15.64B | 18.38B | 2 |
| FQ3 2026 (Jul 2026) | 16.55B | -33.89 | 15.53B | 18.25B | 2 |
| FQ2 2026 (Jun 2026) | 16.55B | 22.83 | 15.41B | 18.3B | 1 |
| FQ1 2026 (Mar 2026) | 16.43B | 29.15 | 15.3B | 18.18B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
1
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2.16909 | 0.84 | -1.32909 | -158.23% |
| FQ2 2025 (Jun 2025) | 2.30442 | 2.6 | 0.29558 | 11.37% |
| FQ1 2025 (Mar 2025) | 1.5 | 1.5 | 100% | |
| FQ4 2024 (Dec 2024) | 4.36 | 4.36 | 100% | |
| FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
| FQ2 2024 (Jun 2024) | 0.49 | 0.49 | 100% | |
| FQ1 2024 (Mar 2024) | 1.7 | 1.7 | 100% | |
| FQ4 2023 (Dec 2023) | 4.19 | 4.19 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $15.18B | $22.16B | $6972.62M | 31.47% |
| FQ2 2025 (Jun 2025) | $15.18B | $12.77B | $-2413.38M | -18.9% |
| FQ1 2025 (Mar 2025) | $0B | $11.64B | $11643M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $13.54B | $13542M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $12.91B | $12908M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $13.24B | $13241M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $13.42B | $13417M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $14.93B | $14934M | 100% |